Six and a half years ago, as the world shut down, Rod Hochman, Providence’s CEO, called. Providence had written an ambitious white paper two years earlier asking a simple question: What if health systems came together to use their collective data to advance science and improve healthcare? Now was the moment to make it real.
I never expected to start another company. After the intensity of co-founding a company in my twenties, and then joining Microsoft, I thought that chapter of my life was behind me. But the pandemic was making painfully clear how urgently healthcare needed what Providence had envisioned. Rod invited me to build it, and the opportunity felt too important to pass up. That white paper became Truveta, a company built to pursue the mission of Saving Lives with Data.
When we started Truveta, I would tell family and friends that my goal was to spend five years building it, then hand it to the next generation of leaders in great shape. I wanted to help build something important and enduring.
It is surreal that, six and a half years later, that day has come. Together with the Board, we have been planning for this transition. Truveta is strong, and the next generation of leaders is ready. Now is the right time. As I pass the torch, my co-founders Jay Nanduri and Ryan Ahern will lead together as co-CEOs.
We started with an idea and no employees, no technology, no customers, and no data. Truveta is now 500 people strong. We built partnerships spanning 30 of the country’s largest health systems, representing more than 800 hospitals and 20,000 clinics, the world’s leading life sciences companies, and the US government. We created an unprecedented, continuously updated dataset representing the healthcare journeys of more than 140 million Americans, now expanding with genomics. We published the first peer-reviewed real-world comparison of Ozempic and Mounjaro for weight loss, answering a question that mattered to millions of people. That finding took us to the Today Show, and research using Truveta Data has now been cited more than 1,000 times in scientific literature. Along the way, we built a substantial and rapidly growing business.
Those milestones make me incredibly proud. But what I will remember most are the people who made them possible: our health system members, our customers, and especially the hundreds of Truvetans who took a chance on an ambitious idea and turned it into something real.
Six and a half years ago, we set out to build something no health system could build alone. Today, I believe Truveta can become far more consequential than we imagined then. Its most exciting chapters are still ahead, and I cannot wait to see what this team accomplishes next.
As for me, my wife Katie and I now get to figure out our next adventure. For now, I’m hoping for a great snow year.
